Product Name: Human IGF-1R Antibody (Cixutumumab, Research Use)
Catalog Number: NBR-0011
Target Name: IGF-1R
Trade Name: Cixutumumab
Antibody Drug Description: Cixutumumab (IMC-A12) is a human monoclonal antibody for the treatment of solid tumors.This drug was developed by ImClone Systems, since acquired by Eli Lilly, using phage display technology from Dyax. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: IGF-1R
Synonyms: CD221; IGFIR; IGFR; JTK13; MGC18216
Target Description: Receptor tyrosine kinase which mediates actions of insulin-like growth factor 1 (IGF1). Binds IGF1 with high affinity and IGF2 and insulin (INS) with a lower affinity.
Ensembl: ENSG00000140443 
Uniprot: P08069